# Dexcom

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dexcom

- Industry: Medical Devices & Equipment
- Headquarters: San Diego, US
- Website: www.dexcom.com
- Total disclosed funding: $53M
- Latest round: Series D (Jan 4, 2005)
- Investors on record: 9

## About

DexCom, Inc. is a provider of continuous glucose sensing technologies and focuses 100% on these technologies. DexCom is tackling the diabetes epidemic by developing sensors that wirelessly transmit glucose readings to patients and their doctors.

## Funding rounds

- Series D, Jan 4, 2005, $23M — Warburg Pincus, Canaan Partners, St. Paul Venture Capital, RWI Ventures, Vertical Group, MDT Advisers, Fog City Capital
- Series C, Jun 3, 2002, $30M — Invesco, Canaan Partners, St. Paul Venture Capital, Windamere Venture Partners, RWI Ventures, MDT Advisers, Fog City Capital

## Investors

- Invesco (https://capitalatlas.ai/funds/invesco) — Series C
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series C, Series D
- St. Paul Venture Capital (https://capitalatlas.ai/funds/st-paul-venture-capital) — Series C, Series D
- Windamere Venture Partners (https://capitalatlas.ai/funds/windamere-venture-partners) — Series C
- RWI Ventures (https://capitalatlas.ai/funds/rwi-ventures) — Series C, Series D
- MDT Advisers — Series C, Series D
- Fog City Capital (https://capitalatlas.ai/funds/fog-city-capital) — Series C, Series D
- Warburg Pincus (https://capitalatlas.ai/funds/warburg-pincus) — Series D
- Vertical Group (https://capitalatlas.ai/funds/vertical-group) — Series D